Adversaries weaponized recruitment fraud to steal cloud credentials, pivot through IAM misconfigurations, and reach AI ...

PQShield, a leading Post-Quantum Cryptography (PQC) solutions provider, has been recognized as a progressive company in MarketsandMarkets' 360Quadrants(TM) evaluation for the Post-Quantum Cryptography ...

CrashFix crashes browsers to coerce users into executing commands that deploy a Python RAT, abusing finger.exe and portable ...

Objectives Female sex and anticitrullinated protein antibodies (ACPA) are associated with higher disease activity in ...

Tanium, a leader in Autonomous IT, today announced that CRN®-a brand of The Channel Company-has selected Tony Beller, senior vice president of global partner sales, and Mark Miller, vice president of ...

Tanium, a leader in Autonomous IT, today announced that CRN (R)--a brand of The Channel Company--has selected Tony Beller, senior vice president of global partner sales, and Mark Miller, vice ...

Mid-market organizations struggle with security tool complexity, underused EDR, and gaps that native XDR and prevention can ...

Learn more about whether Manhattan Associates, Inc. or Qualys, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

A pair of critical-severity vulnerabilities affecting an Ivanti mobile management tool have been exploited in cyberattacks, ...

CCI staff share recent surveys, reports and analysis on risk, compliance, governance, infosec and leadership issues. Share details of your ...

Protagonist (PTGX) is a high-conviction buy: late-stage icotrokinra & rusfertide near 2026 milestones, strong cash runway. Read more here.

JAMA Dermatology recently published the results of a Phase II study of novel TYK2 inhibitor soficitinib (ICP-332) in patients with moderate-to-severe atopic dermatitis (AD). The journal concluded that ...